Latest Articles

This article sheds light on the issue of image integrity in academic publishing and gives advice on how to reduce the risk.

Hello and welcome to the Pulse, the monthly psychedelics industry roundup from Technology Networks and Analytical Cannabis. Here, we’ll highlight some of the most significant psychedelic industry news from the past month, including important announcements, pre-clinical work and the latest from groundbreaking psychedelic clinical trials.

Hundreds of neuroscientists attended the British Neuroscience Association’s (BNA) 2023 Festival of Neuroscience for four days of much-missed in-person networking and debate.

Emerging clinical trial data suggest that psychedelic compounds could benefit both millions of migraineurs and thousands of cluster headache sufferers who find limited benefit from even gold-standard treatments.

In this opinion piece, Jan Wauters discusses why collaboration in science is so important and what the Windsor Framework could mean for research in Europe.

In this op-ed article, Michael Kinch explains his optimism around ChatGPT which, in his words, centers around the possibility that we as a society might start to question "claims" and "truths" that we encounter daily.

A revolutionary gene therapy has become a transformative treatment for children with metachromatic leukodystrophy (MLD). But substantial barriers to access for this groundbreaking therapy remain.

In this article, we discuss the fundamentals of transfection, provide an overview of some of the commonly employed methods and a sample protocol. Finally, we consider some of the key applications of transfection.

Electronic pipettes offer several benefits, but many laboratories are still resistant to making the switch from manual options. This article discusses how equipping your team with electronic pipettes could rapidly pay for itself.

Hello and welcome to the Pulse, the monthly psychedelics industry roundup from Technology Networks and Analytical Cannabis. Here, we’ll highlight some of the most significant psychedelic industry news from the past month, including important announcements, pre-clinical work and the latest from groundbreaking psychedelic clinical trials.